Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study

BACKGROUND: Most oestrogen receptor (ER)-positive early breast cancer diagnosed today is highly curable with multimodality treatment. Systemic adjuvant treatments including endocrine therapy and chemotherapy have made a significant contribution to the increasing cure rates over the past three decade...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Cancer
Autori principali: Yeo, B, Zabaglo, L, Hills, M, Dodson, A, Smith, I, Dowsett, M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2015
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4522631/
https://ncbi.nlm.nih.gov/pubmed/26180920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.222
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi